FOLH1 and prostate cancer: When linked to PSMA-directed antibodies, the gold nanoparticles only accumulate around prostate cancer cells and, by taking advantage of radiation-induced bystander effects, enable the use of relatively low doses of X-rays to effectively destroy the metastatic disease with little or no harm to surrounding normal tissues.